Non Invasive Prenatal Testing Market Size, Share & Trends Report

Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Pregnancy Risk, By Method, By Technology, By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-310-2
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Table of Contents

Chapter 1. Non Invasive Prenatal Testing Market: Methodology and Scope
                   1.1. Market Segmentation
                       1.1.1. Market Definitions
                   1.2. Objectives
                       1.2.1. Objective - 1
                       1.2.2. Objective - 2
                       1.2.3. Objective - 3
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased Database
                       1.4.2. Gvr’s Internal Database
                       1.4.3. Secondary Sources
                       1.4.4. Primary Research
                   1.5. Information or Data Analysis
                       1.5.1. Data Analysis Models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity Flow Analysis
                   1.8. List of Secondary Sources
                   1.9. List of Abbreviations
                   1.10. List of Primary Sources
Chapter 2. Non Invasive Prenatal Testing Market: Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Non Invasive Prenatal Testing Market: Variables, Trends, & Scope
                   3.1. Market Segmentation and Scope
                   3.2. Market Lineage Outlook
                       3.2.1. Parent Market Outlook
                       3.2.2. Related/Ancillary Market Outlook
                   3.3. Market Dynamics
                   3.4. Market Drivers
                       3.4.1. Increasing average maternal age and rising incidence of chromosomal syndromes
                       3.4.2. High demand for early and noninvasive fetal testing procedure
                       3.4.3. Improvements in the reimbursement scenario
                       3.4.4. Rising collaborations and licensing agreements
                   3.5. Market Restraint Analysis
                       3.5.1. Ethical concerns with respect to reproductive genetics
                   3.6. Business Environment Analysis
                       3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
                       3.6.2. Porter’s Five Forces Analysis
                       3.6.3. COVID-19 Impact Analysis
Chapter 4. Gestation Period Business Analysis
                   4.1. Non-Invasive Prenatal Testing Market: Gestation Period Movement Analysis
                   4.2. 0-12 Weeks
                       4.2.1. 0-12 Weeks Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
                   4.3. 13-24 Weeks
                       4.3.1. 13-24 Weeks Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
                   4.4. 25-36 Weeks
                       4.4.1. 25-36 Weeks Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
Chapter 5. Pregnancy Risk Business Analysis
                   5.1. Non-Invasive Prenatal Testing Market: Pregnancy Risk Movement Analysis
                   5.2. High & Average Risk
                       5.2.1. High & Average Risk Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
                   5.3. Low Risk
                       5.3.1. Low Risk Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
Chapter 6. Method Risk Business Analysis
                   6.1. Non-Invasive Prenatal Testing Market: Method Movement Analysis
                   6.2. Ultrasound Detection
                       6.2.1. Ultrasound Detection Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
                   6.3. Biochemical Screening Tests
                       6.3.1. Biochemical Screening Tests Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
                   6.4. Cell-free DNA in Maternal Plasma Tests
                       6.4.1. Cell-free DNA in Maternal Plasma Tests Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
Chapter 7. Technology Risk Business Analysis
                   7.1. Non-Invasive Prenatal Testing Market: Technology Movement Analysis
                   7.2. NGS
                       7.2.1. NGS Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
                   7.3. Array Technology
                       7.3.1. Array Technology Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
                   7.4. PCR
                       7.4.1. PCR Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
                   7.5. Others
                       7.5.1. Others Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
Chapter 8. Product Risk Business Analysis
                   8.1. Non-Invasive Prenatal Testing Market: Product Movement Analysis
                   8.2. Consumables & Reagents
                       8.2.1. Consumables & Reagents Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
                   8.3. Instruments
                       8.3.1. Instruments Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
Chapter 9. Application Risk Business Analysis
                   9.1. Non-Invasive Prenatal Testing Market: Application Movement Analysis
                   9.2. TRISOMY
                       9.2.1. TRISOMY Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
                   9.3. Microdeletion Syndrome
                       9.3.1. Microdeletion Syndrome Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
                   9.4. Others
                       9.4.1. Others Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
Chapter 10. End-use Business Analysis
                   10.1. Non-Invasive Prenatal Testing Market: End-Use Movement Analysis
                   10.2. Hospitals & Clinics
                       10.2.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
                   10.3. Diagnostics Laboratories
                       10.3.1. Diagnostics Laboratories Companies Market, 2018 - 2030 (USD Million)
                   10.4. Academic and Research Institutes
                       10.4.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
Chapter 11. Regional Business Analysis
                   11.1. Non-Invasive Prenatal Testing Market Share By Region, 2023 & 2030
                   11.2. North America
                       11.2.1. North America Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.2.2. U.S.
                           11.2.2.1. Key Country Dynamics
                           11.2.2.2. Target Disease Prevalence
                           11.2.2.3. Competitive Scenario
                           11.2.2.4. Regulatory Framework
                           11.2.2.5. Reimbursement Scenario
                           11.2.2.6. U.S. Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.2.3. Canada
                           11.2.3.1. Key Country Dynamics
                           11.2.3.2. Target Disease Prevalence
                           11.2.3.3. Competitive Scenario
                           11.2.3.4. Regulatory Framework
                           11.2.3.5. Reimbursement Scenario
                           11.2.3.6. Canada Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                   11.3. Europe
                       11.3.1. Europe Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.3.2. Germany
                           11.3.2.1. Key Country Dynamics
                           11.3.2.2. Target Disease Prevalence
                           11.3.2.3. Competitive Scenario
                           11.3.2.4. Regulatory Framework
                           11.3.2.5. Reimbursement Scenario
                           11.3.2.6. Germany Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.3.3. UK
                           11.3.3.1. Key Country Dynamics
                           11.3.3.2. Target Disease Prevalence
                           11.3.3.3. Competitive Scenario
                           11.3.3.4. Regulatory Framework
                           11.3.3.5. Reimbursement Scenario
                           11.3.3.6. UK Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.3.4. France
                           11.3.4.1. Key Country Dynamics
                           11.3.4.2. Target Disease Prevalence
                           11.3.4.3. Competitive Scenario
                           11.3.4.4. Regulatory Framework
                           11.3.4.5. Reimbursement Scenario
                           11.3.4.6. France Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.3.5. Italy
                           11.3.5.1. Key Country Dynamics
                           11.3.5.2. Target Disease Prevalence
                           11.3.5.3. Competitive Scenario
                           11.3.5.4. Regulatory Framework
                           11.3.5.5. Reimbursement Scenario
                           11.3.5.6. Italy Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.3.6. Spain
                           11.3.6.1. Key Country Dynamics
                           11.3.6.2. Target Disease Prevalence
                           11.3.6.3. Competitive Scenario
                           11.3.6.4. Regulatory Framework
                           11.3.6.5. Reimbursement Scenario
                           11.3.6.6. Spain Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.3.7. Denmark
                           11.3.7.1. Key Country Dynamics
                           11.3.7.2. Target Disease Prevalence
                           11.3.7.3. Competitive Scenario
                           11.3.7.4. Regulatory Framework
                           11.3.7.5. Reimbursement Scenario
                           11.3.7.6. Denmark Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.3.8. Sweden
                           11.3.8.1. Key Country Dynamics
                           11.3.8.2. Target Disease Prevalence
                           11.3.8.3. Competitive Scenario
                           11.3.8.4. Regulatory Framework
                           11.3.8.5. Reimbursement Scenario
                           11.3.8.6. Sweden Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.3.9. Norway
                           11.3.9.1. Key Country Dynamics
                           11.3.9.2. Target Disease Prevalence
                           11.3.9.3. Competitive Scenario
                           11.3.9.4. Regulatory Framework
                           11.3.9.5. Reimbursement Scenario
                           11.3.9.6. Norway Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                   11.4. Asia Pacific
                       11.4.1. Asia Pacific Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.4.2. Japan
                           11.4.2.1. Key Country Dynamics
                           11.4.2.2. Target Disease Prevalence
                           11.4.2.3. Competitive Scenario
                           11.4.2.4. Regulatory Framework
                           11.4.2.5. Reimbursement Scenario
                           11.4.2.6. Japan Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.4.3. China
                           11.4.3.1. Key Country Dynamics
                           11.4.3.2. Target Disease Prevalence
                           11.4.3.3. Competitive Scenario
                           11.4.3.4. Regulatory Framework
                           11.4.3.5. Reimbursement Scenario
                           11.4.3.6. China Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.4.4. India
                           11.4.4.1. Key Country Dynamics
                           11.4.4.2. Target Disease Prevalence
                           11.4.4.3. Competitive Scenario
                           11.4.4.4. Regulatory Framework
                           11.4.4.5. Reimbursement Scenario
                           11.4.4.6. India Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.4.5. South Korea
                           11.4.5.1. Key Country Dynamics
                           11.4.5.2. Target Disease Prevalence
                           11.4.5.3. Competitive Scenario
                           11.4.5.4. Regulatory Framework
                           11.4.5.5. Reimbursement Scenario
                           11.4.5.6. South Korea Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.4.6. Australia
                           11.4.6.1. Key Country Dynamics
                           11.4.6.2. Target Disease Prevalence
                           11.4.6.3. Competitive Scenario
                           11.4.6.4. Regulatory Framework
                           11.4.6.5. Reimbursement Scenario
                           11.4.6.6. Australia Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.4.7. Thailand
                           11.4.7.1. Key Country Dynamics
                           11.4.7.2. Target Disease Prevalence
                           11.4.7.3. Competitive Scenario
                           11.4.7.4. Regulatory Framework
                           11.4.7.5. Reimbursement Scenario
                           11.4.7.6. Thailand Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                   11.5. Latin America
                       11.5.1. Latin America Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.5.2. Brazil
                           11.5.2.1. Key Country Dynamics
                           11.5.2.2. Target Disease Prevalence
                           11.5.2.3. Competitive Scenario
                           11.5.2.4. Regulatory Framework
                           11.5.2.5. Reimbursement Scenario
                           11.5.2.6. Brazil Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.5.3. Mexico
                           11.5.3.1. Key Country Dynamics
                           11.5.3.2. Target Disease Prevalence
                           11.5.3.3. Competitive Scenario
                           11.5.3.4. Regulatory Framework
                           11.5.3.5. Reimbursement Scenario
                           11.5.3.6. Mexico Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.5.4. Argentina
                           11.5.4.1. Key Country Dynamics
                           11.5.4.2. Target Disease Prevalence
                           11.5.4.3. Competitive Scenario
                           11.5.4.4. Regulatory Framework
                           11.5.4.5. Reimbursement Scenario
                           11.5.4.6. Argentina Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                   11.6. MEA
                       11.6.1. MEA Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.6.2. South Africa
                           11.6.2.1. Key Country Dynamics
                           11.6.2.2. Target Disease Prevalence
                           11.6.2.3. Competitive Scenario
                           11.6.2.4. Regulatory Framework
                           11.6.2.5. Reimbursement Scenario
                           11.6.2.6. South Africa Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.6.3. Saudi Arabia
                           11.6.3.1. Key Country Dynamics
                           11.6.3.2. Target Disease Prevalence
                           11.6.3.3. Competitive Scenario
                           11.6.3.4. Regulatory Framework
                           11.6.3.5. Reimbursement Scenario
                           11.6.3.6. Saudi Arabia Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.6.4. UAE
                           11.6.4.1. Key Country Dynamics
                           11.6.4.2. Target Disease Prevalence
                           11.6.4.3. Competitive Scenario
                           11.6.4.4. Regulatory Framework
                           11.6.4.5. Reimbursement Scenario
                           11.6.4.6. UAE Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
                       11.6.5. Kuwait
                           11.6.5.1. Key Country Dynamics
                           11.6.5.2. Target Disease Prevalence
                           11.6.5.3. Competitive Scenario
                           11.6.5.4. Regulatory Framework
                           11.6.5.5. Reimbursement Scenario
                           11.6.5.6. Kuwait Non-Invasive Prenatal Testing market, 2018 - 2030 (USD Million)
Chapter 12. Competitive Landscape
                   12.1. Participant’s overview
                   12.2. Financial performance
                   12.3. Participant categorization
                       12.3.1. Market Leaders
                       12.3.2. Non-Invasive Prenatal Testing market Share Analysis, 2023
                       12.3.3. Company Profiles
                           12.3.3.1. Genesis Genetics (CooperSurgical, Inc.)
                               12.3.3.1.1. Company Overview
                               12.3.3.1.2. Financial Performance
                               12.3.3.1.3. Product Benchmarking
                               12.3.3.1.4. Strategic Initiatives
                           12.3.3.2. Natera, Inc.
                               12.3.3.2.1. Company Overview
                               12.3.3.2.2. Financial Performance
                               12.3.3.2.3. Product Benchmarking
                               12.3.3.2.4. Strategic Initiatives
                           12.3.3.3. Centogene N.V.
                               12.3.3.3.1. Company Overview
                               12.3.3.3.2. Financial Performance
                               12.3.3.3.3. Product Benchmarking
                               12.3.3.3.4. Strategic Initiatives
                           12.3.3.4. Eurofins Scientific
                               12.3.3.4.1. Company Overview
                               12.3.3.4.2. Financial Performance
                               12.3.3.4.3. Product Benchmarking
                               12.3.3.4.4. Strategic Initiatives
                           12.3.3.5. MedGenome Labs Ltd.
                               12.3.3.5.1. Company Overview
                               12.3.3.5.2. Financial Performance
                               12.3.3.5.3. Product Benchmarking
                               12.3.3.5.4. Strategic Initiatives
                           12.3.3.6. F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
                               12.3.3.6.1. Company Overview
                               12.3.3.6.2. Financial Performance
                               12.3.3.6.3. Product Benchmarking
                               12.3.3.6.4. Strategic Initiatives
                           12.3.3.7. Myriad Women’s Health, Inc. (Counsyl, Inc.)
                               12.3.3.7.1. Company Overview
                               12.3.3.7.2. Financial Performance
                               12.3.3.7.3. Product Benchmarking
                               12.3.3.7.4. Strategic Initiatives
                           12.3.3.8. Progenity, Inc.
                               12.3.3.8.1. Company Overview
                               12.3.3.8.2. Financial Performance
                               12.3.3.8.3. Product Benchmarking
                               12.3.3.8.4. Strategic Initiatives
                           12.3.3.9. Qiagen
                               12.3.3.9.1. Company Overview
                               12.3.3.9.2. Financial Performance
                               12.3.3.9.3. Product Benchmarking
                               12.3.3.9.4. Strategic Initiatives
                           12.3.3.10. Laboratory Corp. of America Holdings
                               12.3.3.10.1. Company Overview
                               12.3.3.10.2. Financial Performance
                               12.3.3.10.3. Product Benchmarking
                               12.3.3.10.4. Strategic Initiatives
                           12.3.3.11. Illumina, Inc. (Verinata Health, Inc.)
                               12.3.3.11.1. Company Overview
                               12.3.3.11.2. Financial Performance
                               12.3.3.11.3. Product Benchmarking
                               12.3.3.11.4. Strategic Initiatives
                           12.3.3.12. Quest Diagnostics, Inc.
                               12.3.3.12.1. Company Overview
                               12.3.3.12.2. Financial Performance
                               12.3.3.12.3. Product Benchmarking
                               12.3.3.12.4. Strategic Initiatives
                       12.3.4. Strategy Mapping
                           12.3.4.1. Expansion
                           12.3.4.2. Acquisition
                           12.3.4.3. Collaborations
                           12.3.4.4. Product Type/Product Launch
                           12.3.4.5. Partnerships
                           12.3.4.6. Others


List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 Regulatory framework
TABLE 4 Risk of Trisomy 21 and chromosomal abnormalities with maternal age
TABLE 5 Average selling prices of non-invasive prenatal tests
TABLE 6 North America NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 7 North America NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 8 North America NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 9 North America NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 10 North America NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 11 North America NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 12 North America NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 13 North America NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 14 U.S. NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 15 U.S. NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 16 U.S. NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 17 U.S. NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 18 U.S. NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 19 U.S. NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 20 U.S. NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 21 Canada NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 22 Canada NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 23 Canada NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 24 Canada NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 25 Canada NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 26 Canada NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 27 Canada NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 28 Europe NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 29 Europe NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 30 Europe NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 31 Europe NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 32 Europe NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 33 Europe NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 34 Europe NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 35 Europe NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 36 U.K. NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 37 U.K. NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 38 U.K. NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 39 U.K. NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 40 U.K. NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 41 U.K. NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 42 U.K. NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 43 Germany NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 44 Germany NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 45 Germany NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 46 Germany NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 47 Germany NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 48 Germany NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 49 Germany NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 50 France NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 51 France NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 52 France NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 53 France NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 54 France NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 55 France NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 56 France NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 57 Italy NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 58 Italy NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 59 Italy NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 60 Italy NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 61 Italy NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 62 Italy NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 63 Italy NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 64 Spain NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 65 Spain NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 66 Spain NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 67 Spain NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 68 Spain NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 69 Spain NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 70 Spain NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 71 Denmark NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 72 Denmark NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 73 Denmark NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 74 Denmark NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 75 Denmark NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 76 Denmark NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 77 Denmark NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 78 Sweden NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 79 Sweden NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 80 Sweden NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 81 Sweden NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 82 Sweden NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 83 Sweden NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 84 Sweden NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 85 Norway NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 86 Norway NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 87 Norway NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 88 Norway NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 89 Norway NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 90 Norway NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 91 Norway NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 92 Asia Pacific NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 93 Asia Pacific NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 94 Asia Pacific NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 95 Asia Pacific NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 96 Asia Pacific NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 97 Asia Pacific NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 98 Asia Pacific NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 99 Asia Pacific NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 100 Japan NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 101 Japan NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 102 Japan NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 103 Japan NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 104 Japan NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 105 Japan NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 106 Japan NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 107 China NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 108 China NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 109 China NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 110 China NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 111 China NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 112 China NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 113 China NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 114 India NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 115 India NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 116 India NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 117 India NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 118 India NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 119 India NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 120 India NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 121 South Korea NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 122 South Korea NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 123 South Korea NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 124 South Korea NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 125 South Korea NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 126 South Korea NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 127 South Korea NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 128 Australia NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 129 Australia NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 130 Australia NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 131 Australia NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 132 Australia NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 133 Australia NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 134 Australia NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 135 Thailand NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 136 Thailand NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 137 Thailand NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 138 Thailand NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 139 Thailand NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 140 Thailand NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 141 Thailand NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 142 Latin America NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 143 Latin America NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 144 Latin America NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 145 Latin America NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 146 Latin America NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 147 Latin America NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 148 Latin America NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 149 Latin America NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 150 Brazil NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 151 Brazil NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 152 Brazil NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 153 Brazil NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 154 Brazil NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 155 Brazil NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 156 Brazil NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 157 Mexico NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 158 Mexico NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 159 Mexico NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 160 Mexico NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 161 Mexico NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 162 Mexico NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 163 Mexico NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 164 Argentina NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 165 Argentina NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 166 Argentina NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 167 Argentina NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 168 Argentina NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 169 Argentina NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 170 Argentina NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 171 MEA NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 172 MEA NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 173 MEA NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 174 MEA NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 175 MEA NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 176 MEA NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 177 MEA NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 178 MEA NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 179 South Africa NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 180 South Africa NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 181 South Africa NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 182 South Africa NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 183 South Africa NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 184 South Africa NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 185 South Africa NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 186 Saudi Arabia NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 187 Saudi Arabia NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 188 Saudi Arabia NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 189 Saudi Arabia NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 190 Saudi Arabia NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 191 Saudi Arabia NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 192 Saudi Arabia NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 193 UAE NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 194 UAE NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 195 UAE NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 196 UAE NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 197 UAE NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 198 UAE NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 199 UAE NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 200 Kuwait NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 201 Kuwait NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 202 Kuwait NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 203 Kuwait NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 204 Kuwait NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 205 Kuwait NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 206 Kuwait NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Non-Invasive Prenatal Testing Market Segmentation
FIG. 8 Market Snapshot, 2023
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Global Non-Invasive Prenatal Testing Market: Gestation Period Movement Analysis
FIG. 15 Global Non-Invasive Prenatal Testing Market, by 0-12 Weeks, 2018 - 2030 (USD Million)
FIG. 16 Global Non-Invasive Prenatal Testing Market, by 13-24 Weeks, 2018 - 2030 (USD Million)
FIG. 17 Global Non-Invasive Prenatal Testing Market: Pregnancy Risk Movement Analysis
FIG. 18 Global Non-Invasive Prenatal Testing Market, by High & Average Risk, 2018 - 2030 (USD Million)
FIG. 19 Global Non-Invasive Prenatal Testing Market, by Low Risk, 2018 - 2030 (USD Million)
FIG. 20 Global Non-Invasive Prenatal Testing Market: Method Movement Analysis
FIG. 21 Global Non-Invasive Prenatal Testing Market, by Ultrasound Detection, 2018 - 2030 (USD Million)
FIG. 22 Global Non-Invasive Prenatal Testing Market, by Biochemical Screening Tests, 2018 - 2030 (USD Million)
FIG. 23 Global Non-Invasive Prenatal Testing Market, by Cell-free DNA in Maternal Plasma Tests, 2018 - 2030 (USD Million)
FIG. 24 Global Non-Invasive Prenatal Testing Market: Technology Movement Analysis
FIG. 25 Global Non-Invasive Prenatal Testing Market, by NGS, 2018 - 2030 (USD Million)
FIG. 26 Global Non-Invasive Prenatal Testing Market, by Array Technology, 2018 - 2030 (USD Million)
FIG. 27 Global Non-Invasive Prenatal Testing Market, by PCR, 2018 - 2030 (USD Million)
FIG. 28 Global Non-Invasive Prenatal Testing Market, by Others, 2018 - 2030 (USD Million)
FIG. 29 Global Non-Invasive Prenatal Testing Market: Product Movement Analysis
FIG. 30 Global Non-Invasive Prenatal Testing Market, by Consumables & Reagents, 2018 - 2030 (USD Million)
FIG. 31 Global Non-Invasive Prenatal Testing Market, by Instruments, 2018 - 2030 (USD Million)
FIG. 32 Global Non-Invasive Prenatal Testing Market: Application Movement Analysis
FIG. 33 Global Non-Invasive Prenatal Testing Market, by Trisomy, 2018 - 2030 (USD Million)
FIG. 34 Global Non-Invasive Prenatal Testing Market, by Microdeletion Syndrome, 2018 - 2030 (USD Million)
FIG. 35 Global Non-Invasive Prenatal Testing Market, by Other Applications, 2018 - 2030 (USD Million)
FIG. 36 Global Non-Invasive Prenatal Testing Market: End-use Movement Analysis
FIG. 37 Global Non-Invasive Prenatal Testing Market, by Hospitals & Clinics, 2018 - 2030 (USD Million)
FIG. 38 Global Non-Invasive Prenatal Testing Market, by Diagnostic Laboratories, 2018 - 2030 (USD Million)
FIG. 39 Regional Marketplace: Key Takeaways
FIG. 40 Regional Outlook, 2023 & 2030
FIG. 41 Global Non-Invasive Prenatal Testing Market: Region Movement Analysis
FIG. 42 North America Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 43 U.S. Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 44 Canada Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 45 Europe Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 46 Germany Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 47 UK Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 48 France Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 49 Italy Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 50 Spain Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 51 Denmark Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 52 Sweden Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 53 Norway Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 54 Asia Pacific Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 55 Japan Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 56 China Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 57 India Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 58 Australia Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 59 South Korea Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 60 Thailand Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 61 Latin America Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 62 Brazil Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 63 Mexico Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 64 Argentina Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 65 Middle East and Africa Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 66 South Africa Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 67 Saudi Arabia Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 68 UAE Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)
FIG. 69 Kuwait Non-Invasive Prenatal Testing Market, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon